Using telehealth to improve treatment for opioid use disorder after incarceration
Telehealth to Improve Post-Incarceration Treatment for OUD Patients (TIPTOP): AnAcceptability and Feasibility Trial
This study is looking to make it easier for people with opioid use disorder who have just been released from jail to get treatment through telehealth, using a medication called buprenorphine, by gathering feedback from patients and healthcare providers to better understand their needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11074686 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to treatment for individuals with opioid use disorder (OUD) who have recently been released from incarceration. It aims to develop a telehealth protocol for delivering buprenorphine, a medication that helps manage OUD, to address barriers these individuals face in accessing care. The study will gather insights from patients, healthcare providers, and administrators to ensure the telehealth approach meets the specific needs of this population. By identifying predictors of treatment linkage and examining stakeholder perspectives, the research seeks to improve post-release engagement in treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have been recently incarcerated and are struggling with opioid use disorder.
Not a fit: Patients who are not recently released from incarceration or do not have opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose deaths and improve treatment outcomes for individuals with opioid use disorder after incarceration.
How similar studies have performed: Previous research has shown that telehealth approaches can effectively improve access to treatment for various health conditions, suggesting potential success for this novel application in opioid use disorder.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Khatri, Utsha — Icahn School of Medicine at Mount Sinai
- Study coordinator: Khatri, Utsha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.